Loading clinical trials...
Loading clinical trials...
A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use of CUSA-081 for Dysfunctional Central Venous Access Devices (CVADs)
Conditions
Interventions
CUSA-081
Placebo
+1 more
Locations
77
United States
Chiesi Investigational Site
Little Rock, Arkansas, United States
Chiesi Investigational Site
Redlands, California, United States
Chiesi Investigational Site
Stockton, California, United States
Chiesi Investigational Site
Norwich, Connecticut, United States
Chiesi Investigational Site
Newark, Delaware, United States
Chiesi Investigational Site
Jacksonville, Florida, United States
Start Date
February 12, 2020
Primary Completion Date
June 8, 2023
Completion Date
July 10, 2023
Last Updated
August 23, 2024
NCT07410117
NCT03830320
NCT07102160
NCT06658197
NCT05628948
NCT05967741
Lead Sponsor
Chiesi Farmaceutici S.p.A.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions